Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fowler, P. A.
Right arrow Articles by Mason, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, P. A.
Right arrow Articles by Mason, H. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 7, 1353-1358, July 2001
© 2001 European Society of Human Reproduction and Embryology

Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women

Paul A. Fowler1,5, Tarja Sorsa1,2, William J. Harris2, Philip G. Knight3 and Helen D. Mason4

1 Department of Obstetrics and Gynaecology, 2 Department of Molecular and Cell Biology, University of Aberdeen, Aberdeen, 3 School of Animal and Microbial Sciences, University of Reading, Reading and 4 Departments of Obstetrics and Gynaecology and Physiology, St George's Hospital Medical School, London, UK

BACKGROUND: We have previously demonstrated that follicles <=11 mm diameter from women undergoing IVF contain higher concentrations of gonadotrophin surge attenuating factor (GnSAF) bioactivity than large follicles from the same ovaries. METHODS: To determine whether this finding is relevant to spontaneous cycles, follicular fluid aspirated from 37 follicles between 3 and 25 mm in diameter from 14 pairs of ovaries from regularly cycling women undergoing total abdominal hysterectomy and bilateral salpingoophorectomy for benign gynaecological disease was pooled into size categories (3 + 4, 5 + 6, 7 + 8, 9 + 10, 11 + 12, 14 + 15, 18 and 25 mm). These pools were bioassayed for GnSAF and inhibin-A, inhibin-B and activin-A concentrations were determined. RESULTS: Follicles of 5 + 6 mm diameter contained the highest concentrations of GnSAF bioactivity (reducing GnRH-induced LH secretion to 38 ± 8% of control, P < 0.001), while those of 25 mm diameter contained one quarter of this concentration (reducing GnRH-induced LH secretion to 72 ± 2% of control, P < 0.05). GnSAF bioactivity was closely related to follicle size (r = –0.836, P < 0.01), but not to inhibin-A, inhibin-B or activin-A concentrations. CONCLUSIONS: The finding that small follicles contain high concentrations of GnSAF bioactivity, which fall as folliculogenesis progresses during spontaneous cycles, support the hypothesis that GnSAF has a role in preventing the premature onset of the LH surge in women.

Key words: follicle size/GnRH/GnSAF/LH/spontaneous cycle

5 To whom correspondence should be addressed. E-mail: p.a.fowler{at}abdn.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
I. E. Messinis
Ovarian feedback, mechanism of action and possible clinical implications
Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Karligiotou, P. Kollia, A. Kallitsaris, and I.E. Messinis
Expression of human serum albumin (HSA) mRNA in human granulosa cells: potential correlation of the 95 amino acid long carboxyl terminal of HSA to gonadotrophin surge-attenuating factor
Hum. Reprod., March 1, 2006; 21(3): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Dafopoulos, I. Mademtzis, P. Vanakara, A. Kallitsaris, G. Stamatiou, C. Kotsovassilis, and I. E. Messinis
Evidence That Termination of the Estradiol-Induced Luteinizing Hormone Surge in Women Is Regulated by Ovarian Factors
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 641 - 645.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role
Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
P. A Fowler and N. Spears
The cultured rodent follicle as a model for investigations of gonadotrophin surge-attenuating factor (GnSAF) production
Reproduction, June 1, 2004; 127(6): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P. A. Fowler, T. Sorsa-Leslie, P. Cash, B. Dunbar, W. Melvin, Y. Wilson, H. D. Mason, and W. Harris
A 60-66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells
Mol. Hum. Reprod., September 1, 2002; 8(9): 823 - 832.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Martinez, P.N. Barri, B. Coroleu, R. Tur, T. Sorsa-Leslie, W. J. Harris, N. P. Groome, P. G. Knight, and P. A. Fowler
Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles
Hum. Reprod., March 1, 2002; 17(3): 634 - 640.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.